It used to be on the corporate presentations couple years ago. From 08/2017 CP (I have almost all of those CPs), I can see that 3 patients were on the combo H&N trial. Two had a stable disease for a while, but one of them died, while the other continued the treatment. The 3rd patient obviously showed no response and then died. We have never got an update on the combo H&N trial, as it was put on hold first, then shelved. We all thought it was dead, so why Advaxis is trying to resurrect it now? Do they have lots of extra cash to throw around? Beats me.
Do they have lots of extra cash to throw around? Beats me
ADXS beats up everyone - from those seeking treatment/cure, to the shareholders. The longer you have been a shareholder, the more severe the beating is going to be - a bonus for being a customer for so long.
This company is speeding towards BK and there are no imminent roadblocks to prevent that event.
News 
Market Data 
Discover 
AI
